A safety clinical trial shows a possible increased risk of cancer with the weight-loss drug Belviq, Belviq XR. Consider the benefits and risks when deciding to prescribe or continue patients on the drug.
fda.gov
fda.gov
RSS Hunter
2025-02-20
Create attached notes ...